Bill Sponsor
House Bill 1017
115th Congress(2017-2018)
Removing Barriers to Colorectal Cancer Screening Act of 2017
Introduced
Introduced
Introduced in House on Feb 13, 2017
Overview
Text
Introduced in House 
Feb 13, 2017
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Feb 13, 2017)
Feb 13, 2017
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
H. R. 1017 (Introduced-in-House)


115th CONGRESS
1st Session
H. R. 1017


To amend title XVIII of the Social Security Act to waive coinsurance under Medicare for colorectal cancer screening tests, regardless of whether therapeutic intervention is required during the screening.


IN THE HOUSE OF REPRESENTATIVES

February 13, 2017

Mr. Dent (for himself, Mr. Payne, and Mr. Lance) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To amend title XVIII of the Social Security Act to waive coinsurance under Medicare for colorectal cancer screening tests, regardless of whether therapeutic intervention is required during the screening.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Removing Barriers to Colorectal Cancer Screening Act of 2017”.

SEC. 2. Findings.

Congress finds the following:

(1) Colorectal cancer is the second leading cause of cancer death among men and women combined in the United States.

(2) In 2017, more than 135,000 Americans will be diagnosed with colorectal cancer and approximately 50,000 Americans will die from it.

(3) Approximately 60 percent of colorectal cancer cases and 70 percent of deaths occur in those aged 65 and older.

(4) Colorectal cancer screening colonoscopy allows for the detection and removal of polyps, or abnormal growths, that could become cancerous, as well as for the early detection of colorectal cancer when treatment can be most effective.

(5) Although colorectal cancer is largely preventable, one in three adults between the ages of 50 and 75 are not up to date with recommended colorectal cancer screening.

(6) Over 1,000 organizations have committed to eliminating colorectal cancer as a major public health problem and are working toward the shared goal of reaching 80 percent screened for colorectal cancer by 2018.

(7) Colorectal cancer screening colonoscopy is a highly effective preventive service, and removing financial barriers can help to increase screening rates.

SEC. 3. Waiving medicare coinsurance for co­lo­rec­tal cancer screening tests.

(a) In general.—Section 1833(a)(1)(Y) of the Social Security Act (42 U.S.C. 1395l(a)(1)(Y)) is amended by inserting “, including a colorectal cancer screening test (regardless of the code that is billed for the establishment of a diagnosis as a result of the test, or for the removal of tissue or other procedure that is furnished in connection with, as a result of, and in the same clinical encounter as the screening test),” after “section 1861(ddd)(3)”.

(b) Effective date.—The amendment made by this section shall apply to items and services furnished after the date of the enactment of this Act.